eprintid: 97237
rev_number: 3
eprint_status: archive
dir: disk0/00/09/72/37
datestamp: 2026-06-19 05:59:52
lastmod: 2026-06-19 05:59:52
status_changed: 2026-06-19 05:59:52
type: article
metadata_visibility: show
creators_name: Maxmudov Begzod, Maxmudov Begzod
creators_name: Juraqulova Diyora, Juraqulova Diyora
creators_name: Abduaxatov Abdulaziz, Abduaxatov Abdulaziz
creators_name: Azimova Aziza, Azimova Aziza
title: ROLE OF HYPERURICEMIA AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM ACTIVATION IN RENAL DYSFUNCTION
ispublished: pub
keywords: This study is dedicated to investigating hyperuricemia and its associated renal dysfunction mechanisms. Hyperuricemia, characterized by elevated uric acid levels, induces oxidative stress, inflammation, and tubulointerstitial injury. In addition, activation of the renin-angiotensin-aldosterone system (RAAS) exacerbates glomerular and tubular damage, leading to proteinuria, interstitial fibrosis, and glomerulosclerosis. Experimental and clinical studies demonstrate that lowering uric acid levels and modulating RAAS can prevent the decline in kidney function and slow the progression of chronic kidney disease. The results of this work can be applied in the treatment and prevention of patients with hyperuricemia, as well as in guiding clinical management strategies.
abstract: This study is dedicated to investigating hyperuricemia and its associated renal dysfunction mechanisms. Hyperuricemia, characterized by elevated uric acid levels, induces oxidative stress, inflammation, and tubulointerstitial injury. In addition, activation of the renin-angiotensin-aldosterone system (RAAS) exacerbates glomerular and tubular damage, leading to proteinuria, interstitial fibrosis, and glomerulosclerosis. Experimental and clinical studies demonstrate that lowering uric acid levels and modulating RAAS can prevent the decline in kidney function and slow the progression of chronic kidney disease. The results of this work can be applied in the treatment and prevention of patients with hyperuricemia, as well as in guiding clinical management strategies.
date: 2026-02-06
official_url: https://universalconference.us/index.php/icmse/article/view/6606
full_text_status: public
publication: INTERNATIONAL CONFERENCE ON MEDICINE, SCIENCE, AND EDUCATION
volume: 3
number: 1
pagerange: 134-137
citation:   Maxmudov Begzod, Maxmudov Begzod, Juraqulova Diyora, Juraqulova Diyora, Abduaxatov Abdulaziz, Abduaxatov Abdulaziz, Azimova Aziza, Azimova Aziza  (2026) ROLE OF HYPERURICEMIA AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM ACTIVATION IN RENAL DYSFUNCTION.  INTERNATIONAL CONFERENCE ON MEDICINE, SCIENCE, AND EDUCATION, 3 (1).  pp. 134-137.      
document_url: https://arxiv.universalpublishings.com/id/eprint/97237/1/134-137.pdf